| Schedule of Basic and Diluted Net Loss Per Share |
The following table presents the calculation of basic and diluted net loss per share for the three and nine months ended September 30, 2026 and 2025: | | | Three Months Ended
September 30, | | | Nine Months Ended
September 30, | | | | | 2026 | | | 2025 | | | 2026 | | | 2025 | | | Net loss attributable to common stockholders | | $ | (4,937 | ) | | $ | (6,692 | ) | | $ | (27,177 | ) | | $ | (17,073 | ) | | Weighted-average shares outstanding, basic and diluted | | | 109,999,870 | | | | 12,786,148 | | | | 75,945,785 | | | | 12,702,432 | | | Net loss per share, basic and diluted | | $ | (0.04 | ) | | $ | (0.52 | ) | | $ | (0.36 | ) | | $ | (1.34 | ) |
|
| Schedule of Anti-Dilutive Securities |
The following outstanding potential shares of common stock were excluded from the calculation of diluted net loss per share because their effect would have been anti-dilutive for the periods presented: | | | Three Months Ended
September 30, | | | Nine Months Ended
September 30, | | | | | 2026 | | | 2025 | | | 2026 | | | 2025 | | | Redeemable convertible preferred stock | | | — | | | | 50,500,239 | | | | — | | | | 50,500,239 | | | Outstanding stock options | | | 6,742,311 | | | | 7,518,402 | | | | 6,742,311 | | | | 7,518,402 | | | Preferred stock warrants | | | — | | | | 55,154 | | | | — | | | | 55,154 | | | Common stock warrants | | | 4,581,027 | | | | 3,648,890 | | | | 4,581,027 | | | | 3,648,890 | | | Convertible notes | | | — | | | | 3,946,497 | | | | — | | | | 3,946,497 | | | SAFE liabilities | | | — | | | | 14,160,720 | | | | — | | | | 14,160,720 | | | Total | | | 11,323,338 | | | | 79,829,902 | | | | 11,323,338 | | | | 79,829,902 | |
|